Medtronic Operating Income 2012-2025 | MDT
Medtronic annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Medtronic operating income for the quarter ending July 31, 2025 was $1.444B, a 12.81% increase year-over-year.
- Medtronic operating income for the twelve months ending July 31, 2025 was $6.120B, a 18.7% increase year-over-year.
- Medtronic annual operating income for 2025 was $5.956B, a 15.76% increase from 2024.
- Medtronic annual operating income for 2024 was $5.145B, a 6.2% decline from 2023.
- Medtronic annual operating income for 2023 was $5.485B, a 4.66% decline from 2022.
|
Medtronic Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $5,956 |
| 2024 | $5,145 |
| 2023 | $5,485 |
| 2022 | $5,753 |
| 2021 | $4,484 |
| 2020 | $4,791 |
| 2019 | $6,268 |
| 2018 | $6,640 |
| 2017 | $5,383 |
| 2016 | $5,361 |
| 2015 | $3,766 |
| 2014 | $3,813 |
| 2013 | $4,755 |
| 2012 | $4,748 |
| 2011 | $4,297 |
|
Medtronic Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-07-31 | $1,444 |
| 2025-04-30 | $1,437 |
| 2025-01-31 | $1,645 |
| 2024-10-31 | $1,594 |
| 2024-07-31 | $1,280 |
| 2024-04-30 | $1,053 |
| 2024-01-31 | $1,483 |
| 2023-10-31 | $1,340 |
| 2023-07-31 | $1,269 |
| 2023-04-30 | $1,567 |
| 2023-01-31 | $1,391 |
| 2022-10-31 | $1,403 |
| 2022-07-31 | $1,124 |
| 2022-04-30 | $1,672 |
| 2022-01-31 | $1,659 |
| 2021-10-31 | $1,563 |
| 2021-07-31 | $859 |
| 2021-04-30 | $1,604 |
| 2021-01-31 | $1,277 |
| 2020-10-31 | $930 |
| 2020-07-31 | $673 |
| 2020-04-30 | $316 |
| 2020-01-31 | $1,639 |
| 2019-10-31 | $1,351 |
| 2019-07-31 | $1,485 |
| 2019-04-30 | $1,946 |
| 2019-01-31 | $1,542 |
| 2018-10-31 | $1,544 |
| 2018-07-31 | $1,236 |
| 2018-04-30 | $1,928 |
| 2018-01-31 | $1,436 |
| 2017-10-31 | $1,894 |
| 2017-07-31 | $1,382 |
| 2017-04-30 | $1,684 |
| 2017-01-31 | $1,147 |
| 2016-10-31 | $1,385 |
| 2016-07-31 | $1,167 |
| 2016-04-30 | $1,575 |
| 2016-01-31 | $1,355 |
| 2015-10-31 | $1,300 |
| 2015-07-31 | $1,131 |
| 2015-04-30 | $159 |
| 2015-01-31 | $1,275 |
| 2014-10-31 | $1,193 |
| 2014-07-31 | $1,139 |
| 2014-04-30 | $305 |
| 2014-01-31 | $1,025 |
| 2013-10-31 | $1,206 |
| 2013-07-31 | $1,277 |
| 2013-04-30 | $1,191 |
| 2013-01-31 | $1,218 |
| 2012-10-31 | $1,186 |
| 2012-07-31 | $1,160 |
| 2012-04-30 | $1,215 |
| 2012-01-31 | $1,153 |
| 2011-10-31 | $1,221 |
| 2011-07-31 | $1,159 |
| 2011-04-30 | $982 |
| 2011-01-31 | $1,147 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $115.955B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.559B | 24.96 |
| EssilorLuxottica (ESLOY) | France | $168.705B | 0.00 |
| Boston Scientific (BSX) | United States | $146.614B | 33.53 |
| Stryker (SYK) | United States | $136.781B | 27.16 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.709B | 0.00 |
| Agilent Technologies (A) | United States | $41.609B | 26.93 |
| ResMed (RMD) | United States | $35.788B | 24.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.442B | 16.47 |
| Koninklijke Philips (PHG) | Netherlands | $27.029B | 17.65 |
| Terumo (TRUMY) | Japan | $24.148B | 28.61 |
| Insulet (PODD) | United States | $22.134B | 74.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.343B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.690B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.227B | 7.45 |
| Bio-Rad Laboratories (BIO) | United States | $8.390B | 30.07 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.891B | 10.52 |
| Envista Holdings (NVST) | United States | $3.313B | 19.01 |
| ICU Medical (ICUI) | United States | $3.144B | 21.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.944B | 13.06 |
| Haemonetics (HAE) | United States | $2.444B | 10.91 |
| Perrigo (PRGO) | Ireland | $2.078B | 5.21 |
| LeMaitre Vascular (LMAT) | United States | $1.953B | 41.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.917B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.858B | 11.95 |
| Phibro Animal Health (PAHC) | United States | $1.668B | 16.66 |
| AtriCure (ATRC) | United States | $1.607B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.437B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.421B | 62.27 |
| AdaptHealth (AHCO) | United States | $1.399B | 20.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.363B | 0.00 |
| Neogen (NEOG) | United States | $1.349B | 25.88 |
| BioLife Solutions (BLFS) | United States | $1.321B | 2757.00 |
| InMode (INMD) | Israel | $0.918B | 10.38 |
| Valneva SE (VALN) | France | $0.774B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.492B | 16.94 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Evolus (EOLS) | United States | $0.441B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.384B | 0.00 |
| Brainsway (BWAY) | Israel | $0.307B | 62.19 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.278B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.273B | 0.00 |
| High Tide (HITI) | Canada | $0.263B | 0.00 |
| Owens & Minor (OMI) | United States | $0.259B | 2.60 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 148.67 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.49 |
| Sanara MedTech (SMTI) | United States | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| Exagen (XGN) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.222B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.210B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.38 |
| FitLife Brands (FTLF) | United States | $0.184B | 22.66 |
| Biote (BTMD) | United States | $0.145B | 5.86 |
| Sharps Technology (STSS) | United States | $0.119B | 0.00 |
| Apyx Medical (APYX) | United States | $0.119B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.99 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Nephros (NEPH) | United States | $0.060B | 47.42 |
| ImmuCell (ICCC) | United States | $0.057B | 33.16 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 12.50 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |